Her surgeon is scheduled, her prior authorization is approved, and her surgery date is locked in for January. What her insurer has not told her could unravel all three.
Gerelyn Terzo UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding…
A retired man collects Social Security and a pension, adds $1,000 a month from a popular Treasury fund, and ends up handing the IRS a bill he never needed to pay. The…
UnitedHealthcare's October prior authorization cuts generated headlines about 1,700 procedures, but Medicare Advantage members searching for their scheduled procedure on that list are finding a very different number staring back at them.
Gerelyn Terzo One number buried inside a popular Dow ETF quietly hands a smaller company more of your retirement dollars than a corporate giant worth more than ten times as much, and the reason…
A fresh analyst upgrade is sending Humana (NYSE:HUM | HUM Price Prediction) shares sharply higher, and the rally stands apart from a quiet managed care group. Humana stock is up 7% to…
Three companies with nothing in common all sent dividend checks on the same September day, but only one of them handed shareholders a freshly raised rate. Which one broke from the pack,…
Most beginners chase the highest yield they can find and end up owning a ticking time bomb. One fund built around a completely different logic has quietly turned $2,000 starting positions into…
A 15-year scorecard just revealed how badly active dividend fund managers fared against a passive benchmark, and the results raise a pointed question about whether the most popular dividend ETF belongs in…
A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash…
TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped…
While Wall Street piles into AI darlings, Michael Burry is quietly loading up on call options in three stocks the market left for dead, and his biggest bets carry a very specific…
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a…
SCHD just delivered a return most dividend investors spend a decade waiting for, and that success created a problem nobody predicted. Whether fresh money belongs in the fund right now depends on…
Mark Cuban says AI will never replace radiologists, and his reasoning has nothing to do with capability. The real disruption, he argues, targets a different layer of medicine entirely, one worth hundreds…
